EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Overview of oxidative stress and inflammation in diabetes

Roni Weinberg Sibony iD, Omri Segev, Saar Dor, Itamar Raz

Journal of Diabetes · 2024-10 · 16 (10)

DOI: 10.1111/1753-0407.70014 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Diabetes, online erschienen am 22.10.2024. Verfasst von Roni Weinberg Sibony und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Ben-Gurion University of the Negev, Beer Sheva, Israel. Hauptthemen laut MEDLINE: Oxidative Stress, Inflammation, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 310-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The global prevalence of diabetes has increased significantly, leading to various complications and a negative impact on quality of life. Hyperglycemia hyperglycemic‐induced oxidative stress (OS) and inflammation are closely associated with the development and progression of type 2 diabetes mellitus (T2D) and its complications. This review explores the effect of T2D on target organ damage and potential treatments to minimize this damage. The paper examines the pathophysiology of T2D, focusing on low‐grade chronic inflammation and OS and on their impact on insulin resistance. The review discusses the role of inflammation and OS in the development of microvascular and macrovascular complications. The findings highlight the mechanisms by which inflammatory cytokines, stress kinases, and reactive oxygen species (ROS) interfere with insulin signaling pathways, leading to impaired glucose metabolism and organ dysfunction. Lifestyle interventions, including a balanced diet and exercise, can help reduce chronic inflammation and OS, thereby preventing and controlling T2D and its associated complications. Additionally, various antioxidants and anti‐inflammatory agents show potential in reducing OS and inflammation. Some anti‐diabetic drugs, like pioglitazone, metformin, and glucagon‐like peptide‐1 (GLP‐1) agonists, may also have anti‐inflammatory effects. Further research, including randomized controlled trials, is needed to evaluate the efficacy of these interventions. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oxidative StressInflammationDiabetes Mellitus, Type 2HumansHypoglycemic AgentsInsulin ResistanceAntioxidants

Stichwörter der Autor:innen

OSinflammationinsulin resistancetype 2 diabetes mellitus

Substanzen

Hypoglycemic AgentsAntioxidants

Autor:innen und Institutionen

  • Faculty of Medicine, Ben-Gurion University of the Negev, Beer Sheva, Israel.
  • Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, Jerusalem, Israel.

ORCID-Profile: Roni Weinberg Sibony

Zitieren

APA

Weinberg Sibony, R., Segev, O., Dor, S., & Raz, I. (2024). Overview of oxidative stress and inflammation in diabetes. Journal of Diabetes, 16(10). https://doi.org/10.1111/1753-0407.70014

Vancouver

Weinberg Sibony R, Segev O, Dor S, Raz I. Overview of oxidative stress and inflammation in diabetes. Journal of Diabetes. 2024;16(10). doi:10.1111/1753-0407.70014

BibTeX
@article{WeinbergSibony2024,
  author = {Weinberg Sibony, Roni and Segev, Omri and Dor, Saar and Raz, Itamar},
  title = {Overview of oxidative stress and inflammation in diabetes},
  journal = {Journal of Diabetes},
  year = {2024},
  volume = {16},
  number = {10},
  doi = {10.1111/1753-0407.70014}
}
Kostenlos starten →